BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8201308)

  • 1. The acute effects of a rapid medical detoxification upon dysphoria and other psychopathology experienced by heroin abusers.
    Ness R; Handelsman L; Aronson MJ; Hershkowitz A; Kanof PD
    J Nerv Ment Dis; 1994 Jun; 182(6):353-9. PubMed ID: 8201308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organic mood syndrome associated with detoxification from methadone maintenance.
    Kanof PD; Aronson MJ; Ness R
    Am J Psychiatry; 1993 Mar; 150(3):423-8. PubMed ID: 8434657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dysphoria of heroin addiction.
    Handelsman L; Aronson MJ; Ness R; Cochrane KJ; Kanof PD
    Am J Drug Alcohol Abuse; 1992; 18(3):275-87. PubMed ID: 1329491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mood disorder history and personality assessment in premenstrual dysphoric disorder.
    Critchlow DG; Bond AJ; Wingrove J
    J Clin Psychiatry; 2001 Sep; 62(9):688-93. PubMed ID: 11681764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of withdrawal symptoms during opioid detoxification.
    Dijkstra BA; Krabbe PF; De Jong CA; van der Staak CP
    J Opioid Manag; 2008; 4(5):311-9. PubMed ID: 19070269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimensions of self-concept: a comparison of heroin and cocaine addicts.
    Fieldman NP; Woolfolk RL; Allen LA
    Am J Drug Alcohol Abuse; 1995 Aug; 21(3):315-26. PubMed ID: 7484982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.
    Gossop M; Strang J
    Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
    J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine versus heroin dependence: comparison of toxicologic and psychopathologic characteristics.
    Torrens M; San L; Camí J
    Am J Psychiatry; 1993 May; 150(5):822-4. PubMed ID: 8480833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric diagnoses of treatment-seeking cocaine abusers.
    Rounsaville BJ; Anton SF; Carroll K; Budde D; Prusoff BA; Gawin F
    Arch Gen Psychiatry; 1991 Jan; 48(1):43-51. PubMed ID: 1984761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of object relations and reality testing in methadone patients.
    Rutherford MJ; Cacciola JS; Alterman AI; McKay JR
    Am J Psychiatry; 1996 Sep; 153(9):1189-94. PubMed ID: 8780424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers.
    Brooner RK; King VL; Kidorf M; Schmidt CW; Bigelow GE
    Arch Gen Psychiatry; 1997 Jan; 54(1):71-80. PubMed ID: 9006403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of opioid physical dependence in heroin addicts.
    Kanof PD; Aronson MJ; Ness R; Cochrane KJ; Horvath TB; Handelsman L
    Drug Alcohol Depend; 1991 May; 27(3):253-62. PubMed ID: 1884668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axis II comorbidity in substance abusers.
    Nace EP; Davis CW; Gaspari JP
    Am J Psychiatry; 1991 Jan; 148(1):118-20. PubMed ID: 1984695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open trial of low dose buprenorphine in treating methadone withdrawal.
    Banys P; Clark HW; Tusel DJ; Sees K; Stewart P; Mongan L; Delucchi K; Callaway E
    J Subst Abuse Treat; 1994; 11(1):9-15. PubMed ID: 8201637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine abuse among heroin addicts in Spain.
    Torrens M; San L; Peri JM; Olle JM
    Drug Alcohol Depend; 1991 Jan; 27(1):29-34. PubMed ID: 2029857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of anxiety and depression on completion/withdrawal status in patients admitted to substance abuse detoxification program.
    Araujo L; Goldberg P; Eyma J; Madhusoodanan S; Buff DD; Shamim K; Brenner R
    J Subst Abuse Treat; 1996; 13(1):61-6. PubMed ID: 8699544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperament characteristics, as assessed by the tridimensional personality questionnaire, moderate the response to sertraline in depressed opiate-dependent methadone patients.
    Raby WN; Carpenter KM; Aharonovich E; Rubin E; Bisaga A; Levin F; Nunes EV
    Drug Alcohol Depend; 2006 Feb; 81(3):283-92. PubMed ID: 16182468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.